Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ScienceBased Health Welcomes Ike K. Ahmed, MD, FRSC and Lisa C. Olmos, MD, MBA to Scientific Advisory Board
  • USA - English


News provided by

ScienceBased Health

Oct 30, 2014, 08:35 ET

Share this article

Share toX

Share this article

Share toX

Ike K. Ahmed, MD, FRSC
Ike K. Ahmed, MD, FRSC

Houston, TX (PRWEB) October 30, 2014 -- ScienceBased Health, a leading provider of premium nutraceuticals for eye health, today announced the appointment of Ike K. Ahmed, MD, FRCSC and Lisa C. Olmos, MD, MBA to its Scientific Advisory Board.

"Dr. Ahmed is internationally recognized for diagnosing and treating highly complex eye diseases,” said Alain Magro, president and CEO of ScienceBased Health. "His accomplishments also include the development of novel glaucoma and cataract microsurgical devices and techniques. We are particularly excited to draw upon his expertise in the field of glaucoma as we continue to examine the role of nutrition in this area.”

"Dr. Olmos has expertise in treating retinal degenerations, experience in designing and leading clinical investigations, and a keen interest in ocular nutrition,” said Mr. Magro. "These skills mesh beautifully with our goals and endeavors, and we look forward to our future collaborations.”

“I am looking forward to being a part of ScienceBased Health’s Scientific Advisory Board,” said Dr. Ahmed. “I believe nutraceuticals play an important role in the prevention and treatment of eye disease. ScienceBased Health has a very strong scientific philosophy and evidence-based approach to the development of its products.”

“As we learned from the original AREDS clinical trial, proper nutritional support can be pivotal in maintaining ocular health and reducing the burden of blinding eye disease,” said Dr. Olmos. “That is why I am so pleased to be working with the ScienceBased Health team to support their mission to maintain the highest scientific standards in analyzing emerging nutrition research.”

Ike K. Ahmed, MD, FRCSC is Assistant Professor, Department of Ophthalmology at the University of Toronto, where he directs research at the Kensington Eye Institute and the Glaucoma and Advanced Anterior Surgical Fellowship program. He has authored a myriad of peer-reviewed journal articles and book chapters, and serves on the editorial boards of publications, such as Ophthalmology, Canadian Journal of Ophthalmology and formerly the Journal of Cataract and Refractive Surgery. Dr. Ahmed is the recipient of numerous awards, most recently the 2014 Binkhorst Medal from the American Society of Cataract and Refractive Surgeons. In 2010, Dr. Ahmed was selected as one of Canada’s “Top 40 Under 40”. Dr. Ahmed received his doctorate of medicine from the University of Toronto, where he did his medical and surgical internship and ophthalmology residency. He completed a fellowship in glaucoma and anterior segment at the Moran Eye Center, University of Utah, and was later appointed Clinical Assistant Professor.

Lisa C. Olmos de Koo, MD, MBA is an Assistant Professor of Ophthalmology in the division of vitreoretinal surgery at the University of Southern California’s Keck School of Medicine in Los Angeles, where she is the director of the surgical retina fellowship program at the USC Eye Institute. Dr. Olmos is the Primary Investigator of the Argus trial at USC and is currently leading USC in the commercial launch of the Argus II Retinal Implant for patients with retinitis pigmentosa and related retinal degenerations. She also has research experience in macular degeneration and diabetic retinopathy. Dr. Olmos received a bachelor’s degree in chemistry from Harvard University, an MBA from Rice University, and a medical degree from Baylor College of Medicine, where she was the recipient of the American Medical Women's Association scholastic achievement award. Dr. Olmos completed a medical internship at Georgetown University/Inova Fairfax Hospital, and completed her residency and vitreoretinal fellowship at the world-renowned Bascom Palmer Eye Institute at the University of Miami. In her final year in Miami, she served as Chief Resident, Clinical Instructor, and Co-Director of Ocular Trauma. Dr. Olmos has been voted one of Pasadena’s “Top Doctors” for 3 consecutive years from 2012-2014, and she was the recipient of a “Rising Star” award from Los Angeles Magazine in 2013.

Drs. Ahmed and Olmos de Koo join SBH’s Scientific Advisory Board members: Paul S. Bernstein, MD, PhD, Associate Professor of Ophthalmology and Visual Sciences, Retina Division, Moran Eye Center, University of Utah School of Medicine; Jeffrey B. Blumberg PhD, FACN, FASN, CNS, Professor, Friedman School of Nutrition Science and Policy and Director, Antioxidants Research Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University; Alon Harris, MD, PhD, FARVO, Alon Harris, PhD, Professor of Ophthalmology and Cellular & Integrative Physiology, Indiana University School of Medicine; Douglas S, Koch, MD, Professor and The Allen, Mosbacher, and Law Chair in Ophthalmology, Cullen Eye Institute, Baylor College of Medicine; Paul S. Koch, MD, Medical Director, Koch Eye Associates; Stephen C. Pflugfelder, MD, Director, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine; and John D. Sheppard, MD, MMSc, Ophthalmology Program Director, Eastern Virginia Medical School, Clinical Director of the Thomas R. Lee Center for Ocular Pharmacology and President, Virginia Eye Consultants.

About ScienceBased Health
ScienceBased Health®, a privately held company founded in 1997, develops and markets evidence-based nutraceuticals for eye health. The Company’s formulations include: HydroEye®, a clinically tested, patented oral formulation for dry eyes; OcularProtect®, a comprehensive multinutrient for eyes and overall body health; MacularProtect Complete® AREDS2, a powerful formulation to preserve macular and whole body health, based on AREDS, AREDS2 and other advanced research; OmegaAdvance®, a premium quality omega 3 supplement; Optic Nerve Formula®, a powerful formulation to protect optic nerve health; DiaVis®, a specialized formulation to support retinal circulation; and other high quality products. The formulations are based on the latest science, made from premium ingredients and manufactured according to highest quality standards in NSF® certified facilities. For more information, contact ScienceBased Health at: (888) 433-4726 or visit: http://www.SBH.com.

####

Pamela Damsen, ScienceBased Health, http://www.sbh.com, +1 (415) 388-7287, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.